CERS
Price
$1.60
Change
+$0.09 (+5.96%)
Updated
Sep 23 closing price
Capitalization
306.72M
36 days until earnings call
UTMD
Price
$63.01
Change
-$0.26 (-0.41%)
Updated
Sep 23 closing price
Capitalization
201.99M
Interact to see
Advertisement

CERS vs UTMD

Header iconCERS vs UTMD Comparison
Open Charts CERS vs UTMDBanner chart's image
Cerus
Price$1.60
Change+$0.09 (+5.96%)
Volume$2.33M
Capitalization306.72M
Utah Medical Products
Price$63.01
Change-$0.26 (-0.41%)
Volume$8.17K
Capitalization201.99M
CERS vs UTMD Comparison Chart in %
Loading...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERS vs. UTMD commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERS is a Buy and UTMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (CERS: $1.60 vs. UTMD: $63.01)
Brand notoriety: CERS and UTMD are both not notable
CERS represents the Medical/Nursing Services, while UTMD is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CERS: 178% vs. UTMD: 70%
Market capitalization -- CERS: $306.72M vs. UTMD: $201.99M
CERS [@Medical/Nursing Services] is valued at $306.72M. UTMD’s [@Pharmaceuticals: Other] market capitalization is $201.99M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $236.51B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.51B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.53B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERS’s FA Score shows that 0 FA rating(s) are green whileUTMD’s FA Score has 0 green FA rating(s).

  • CERS’s FA Score: 0 green, 5 red.
  • UTMD’s FA Score: 0 green, 5 red.
According to our system of comparison, UTMD is a better buy in the long-term than CERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERS’s TA Score shows that 6 TA indicator(s) are bullish while UTMD’s TA Score has 5 bullish TA indicator(s).

  • CERS’s TA Score: 6 bullish, 4 bearish.
  • UTMD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CERS is a better buy in the short-term than UTMD.

Price Growth

CERS (@Medical/Nursing Services) experienced а +26.98% price change this week, while UTMD (@Pharmaceuticals: Other) price change was +1.31% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.80%. For the same industry, the average monthly price growth was +5.57%, and the average quarterly price growth was +9.35%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.06%. For the same industry, the average monthly price growth was -1.49%, and the average quarterly price growth was +7.32%.

Reported Earning Dates

CERS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (+1.80% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.06% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CERS($307M) has a higher market cap than UTMD($202M). UTMD YTD gains are higher at: 4.136 vs. CERS (3.896). UTMD has more cash in the bank: 82.2M vs. CERS (78M). UTMD has less debt than CERS: UTMD (256K) vs CERS (98.9M).
CERSUTMDCERS / UTMD
Capitalization307M202M152%
EBITDA-8.62MN/A-
Gain YTD3.8964.13694%
P/E RatioN/A16.80-
Revenue193MN/A-
Total Cash78M82.2M95%
Total Debt98.9M256K38,633%
FUNDAMENTALS RATINGS
CERS vs UTMD: Fundamental Ratings
CERS
UTMD
OUTLOOK RATING
1..100
263
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9769
PRICE GROWTH RATING
1..100
4850
P/E GROWTH RATING
1..100
10036
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (37) in the Medical Specialties industry is in the same range as UTMD (56). This means that CERS’s stock grew similarly to UTMD’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as UTMD (100). This means that CERS’s stock grew similarly to UTMD’s over the last 12 months.

UTMD's SMR Rating (69) in the Medical Specialties industry is in the same range as CERS (97). This means that UTMD’s stock grew similarly to CERS’s over the last 12 months.

CERS's Price Growth Rating (48) in the Medical Specialties industry is in the same range as UTMD (50). This means that CERS’s stock grew similarly to UTMD’s over the last 12 months.

UTMD's P/E Growth Rating (36) in the Medical Specialties industry is somewhat better than the same rating for CERS (100). This means that UTMD’s stock grew somewhat faster than CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CERSUTMD
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
69%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
61%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
61%
Advances
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 9 days ago
57%
Declines
ODDS (%)
Bearish Trend 10 days ago
84%
Bearish Trend 16 days ago
47%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
65%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADRZF70.65N/A
N/A
Andritz AG
RHCGF1.43N/A
N/A
Ryman Healthcare Ltd.
BBOE0.75N/A
N/A
Black Box Entertainment Ltd.
CIIHY34.07N/A
N/A
Citic Securities Co., Ltd.
DEDVF5.36-0.16
-2.90%
DECISIVE DIVID CORP.

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with UTMD. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then UTMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+5.96%
UTMD - CERS
45%
Loosely correlated
-0.41%
BLFS - CERS
45%
Loosely correlated
-2.10%
CLPT - CERS
44%
Loosely correlated
+1.08%
TWST - CERS
43%
Loosely correlated
-0.61%
NNOX - CERS
43%
Loosely correlated
-1.00%
More

UTMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTMD has been loosely correlated with NVST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if UTMD jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTMD
1D Price
Change %
UTMD100%
-0.41%
NVST - UTMD
49%
Loosely correlated
-0.24%
ITGR - UTMD
48%
Loosely correlated
-0.48%
INMD - UTMD
46%
Loosely correlated
-0.47%
AVNS - UTMD
45%
Loosely correlated
-1.24%
TMCI - UTMD
45%
Loosely correlated
-1.45%
More